The in vitro blastogenesis response of lymphocytes from 19 patients, with either visceral or mucocutaneous leishmaniasis or Chagas disease, to antigens of the Leishtnania-Typanosoma complex was studied. Cells from all patients responded to both homologous and heterologous antigens and the magnitude of the responses did not differ for any of the patient groups or antigens.
Introduction
Chagas disease and visceral and cutaneous leishmaniasis are caused by intracellular protozoa of the Leishmania-Ttypanosoma complex. Biological and biochemical similarities have been documented among these parasites (DWYER, 1977; MOLYNEUX 81 ASHFORD, 1983) . Cross-reactivity occurs with the complement fixation test, immunofluorescence antibody test, and direct agglutination reaction (CAMAR-GO et al., 1973; CAMARGO & REBONATO, 1969; FIFE & KENT, 1960) ; some distinction is possible between these diseases using the enzyme-linked itnmunosorbent assay (ELBA) (GUIMARES et al:, 1981) .
Chagas disease and both forms of lelshtnaniasis are endemic in the state of Bahia, Brazil (CUBA CUBA et al., 1980; Mo-rr et al., 1976; SHERLOCK, 1965; TEIXEIRA et al., 1978b) . The present study examines whether a lymphocyte blastogenesis assay employing T. cruzi, L. mexicana amazonensis, and L. donovani chagasi antigens exhibits specificity which would distinguish between these diseases.
Materials and Methods The subjects included 7 active cutaneous leishmaniasis (ACL) patients, 6 subjects with treated American visceral leishmaniasis (AVL), 6 chronic Chagas disease patients, and 6 healthy volunteers. The patients resided in areas of the state of Bahia which were recognized as having only one of these three diseases. The diagnosis of cutaneous leishmaniasis was based on clinical e;camination, positive Leishmania skin test, and positive Leishmania serology. The age of the ACL patients ranged from 6 to 48 years with a mean of 27 + 15 vears. 2 oatients had onlv cutaneous lesions and 5 had nasalmucosailesions. 5 of the 7 had not received specific therapy at the time of the study; 2 patients had received 2 courses of pentavalent antimonials in-the past but the disease had recurred. The 6 treated AVL patients had the diagnosis of leishmaniasis established by the isolation of L. donovani chugasi from bone marrow aspirates. They were treated with one or more courses of pentavalent antimony 3 to 8 years (mean 5.1 years) before being studied. The treated AVL group had an age range from 4 to 18 years with a mean of 11 + 5.1 years. The diagnosis of chronic Chagas disease was established in 6 patients-by clinical and serologic evaluation. The mean age of the Chagas patients was 30 + 10 years, with ages ranging from 19 to 49 years. 5 of the 6 patients had heart disease characterized by arrhythmias; heart failure was present in 3 patients. The only patient that did not have heart involvement had a megacolon documented by x-ray. 6 healthy medical students and hospital employees served as controls.
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A strain of L. mexicana ama.zonensis (MHOM/BR/76/ Josepha), which was isolated from a patient with cutaneous leishmaniasis in the state of Goias, was used as an antigen source. The strain was initiallv cultured in NNN medium and subsequently maintained h 199 medium supplemented with foetal calf serum. The strain was characterized by isoenzymes, kinetoplast DNA, and monoclonal antibodies. A strain of I.. d. chugasi (MHOM/BIU82/BA-3), isolated from the bone marrow of a patient in the state of Bahia, was another source of antigen (CAFWALHO et al., 1981) . T. cmai (Tulahuen strain) antigen was prepared from epimastigotes cultured in the dialvsate. medium of NAKAMURA (19671. Antigens were prepared in the following manner. L&m&r promastigotes and 2'. crusi epimastigotes were washed three times in phosphate buffered saline (PBS), resuspended in PBS, and rapidly frozen (-70°C) and thawed (37°C) six times. The lysate was sonicated and centrifuged (14 OOOg) for 30 minutes. The supematant was collected and the protein concentration was determined by the method of LOWRY et al. (1951) . The antigen preparations were stored at -20°C and used in concentrations ranging from 0.5 to 25ug of protein per ml of cell culture medium.
Human peripheral blood mononuclear cells were separated from heparinated venous blood by density gradient centrifugation using lymphocyte separation medium (Bionetics Products Laboratories, Kensington, MD) as previously described (WHO/IARC Workshop, 1974) . The mononuclear cell band was washed twice in RPM1 (Gibco Laboratories, Grand Island, New York, USA) and incubated at 37°C for 1 hour. The cells were washed and resusuended in RPM1 supplemented with 15% heated (56°C for'30 min) pooled human AB+ serum at a final concentration of lo6 cells per ml. Aliquots (0.2 ml) of this cell suspension were cultured in triplicate in flat bottomed microtitre plates (Linbro Chemical Co., New Haven, Connecticut, USA) with L. mexicana, L. donovani chagasi, and T. cruai antigens in concentrations ranging from 0.5 to 2~5cLp/ml of culture media. The cell cultures were incubated for five days at 37°C in 5% COr -95% air. After a 4% h pulse of cell cultures with 1 uCi of 3H-thymidine (6.7 Ci/mM) (New England Nuclear Corp., Boston, Massachusetts, USA) the cells were harvested and 3H-thymidine incorporation measured.
Results
The lymphocyte reactivity of the leishtnaniasis and Chagas disease patients to the Leishmania and T. cruzi antigens is shown in In general, the mean response of the 3 groups of patients to both homologous and heterologous antigens was increased at the higher antigen concentrations. However, these differences were not significant for any of the patient groups or antigens (P>O*O5). The only significant difference observed was the difference in the mean response of the six AVL patients to L. d. chagasi and T. cruzi antigens at a concentration of 0*5pg of protein/ml. Discussion These results indicate that patients with leishmaniasis and Chagas disease respond to both homologous and heterologous antigens in an in vitro lymphocyte blastogenesis assay. Although the response to the homologous antigen was generally greater than the responses to heterologous antigens, the only significant difference was that of the visceral leishmaniasis patients to L. d. chagasi and T. mzi antigens. This latter finding is consistent with a specificity we have observed in the delayed-type hypersensitivity skin test in AVL and Chagas disease patients employing the same L. d. chagasi antigen as was used in the blastogenesis assay (R. Badaro et al., personal communication). In these studies, positive skin tests were obtained with 25wg of L. d. chugasi protein in 37 of 40 subjects with cured visceral leishmaniasis and in none of 30 patients with chronic Chagas disease.
The cross reactivity observed in the blastogenesis assay indicates that it is not of diagnostic value in patients with leishmaniasis and Chagas disease. It does raise complex questions as to how concomitant infection with T. cruzi and L.&mania might influence each other. Present knowledge of host defence and pathogenesis of these diseases (CARVALHO et al., 1981; MURRAY et al., 1982; N~CUEIRA et al., 1982; SADICURSKY et al., 1982; TEIXEIRA et al., 1978) This book starts with a useful, if brief, review of tsetse flies, the trypanosomes they transmit, and the vertebrate hosts of both. Finer points of parasite structure and taxonomy are not dealt with. Then follow a chapter each on the human and animal trypanosomiases which, again, provide useful summaries on an inevitably superficial level. The book then moves on, via an introduction to tsetse ecology, to its major concern -methods and effects of controlling trypanosomiasis, mainly by controlling its vector. Perhaps the most valuable part of the book, and the most interesting to me, is the three chapters reviewing methods of tsetse control. The effects of human settlement, and the economics of control (a subject barely studied), are discussed, and the author then considers the interactions between control and land usage -a topic largely ignored in the early, naively optimistic days of control. The penultimate chapter interestingly discusses three current controversies, introduced by three "emotive statements" -"removal of tsetse flies results in land degradation", "insecticides used for tsetse control are polluting Review Africa", and "a better choice: wildlife, not cattle". To these statements, the author's responses can be summarized, respectively, as: not necessarily true, not if we are careful, and unrealistic. The final chapter considers "The future?" -and the question mark is significant. Jordan concludes that "techniques for effectively controlling trypanosmiasis are available, [but] the difficulties of applying them are immense.. .". He challenges the view that control should be given low priority, or even, in the late John Ford's view (1971: The role of the trypanosomes in African ecology. Clarendon Press, Oxford), deliberately not be pursued in the hope that a (perhaps mythical) erstwhile state of biological harmony will be reacquired.
In conclusion, this is not a textbook, not a reference work, but it is a book to be read with interest and enjoyment by everyone -lay person, physician or scientist -with an interest in Africa and Africans and particularly by those with a role to play in planning the future development of African nations. The book is well referenced (over 450 citations) and indexed, and well produced (I did not notice a single misprint).
